Exploratory clinical trial of KIB-PCI in healthy Japanese childre
Phase 2
- Conditions
- Prophylaxis of new type of influenza infection
- Registration Number
- JPRN-jRCT2080222144
- Lead Sponsor
- DAIICHISANKYO Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
1) healthy Japanese children
Exclusion Criteria
1) Subjects with history of H5N1 influenza
2) Subjects with history of H5N1 influenza vaccination
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SRH antibody titer
- Secondary Outcome Measures
Name Time Method HI antibody titer<br>Neutralizing antibody titer